Anodyne Nanotech

Vaxess

This deep-tech company develops microarray patches to provide needle-free, self-administered therapy delivery for patients requiring injectable treatments such as GLP-1.

Nanodyne

Nanodyne develops non-invasive microfluidic skin sensors for continuous monitoring of blood glucose and other biometrics for healthcare providers and patients.

Transdermal Diagnostics

This company develops needle-free, continuous glucose monitoring patches for people living with diabetes and prediabetes to manage blood sugar levels non-invasively.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

Micron Biomedical

This company develops dissolvable microarray patches for needle-free delivery of vaccines and therapeutics to patients in military and global health sectors.

Biolinq

This company develops wearable intradermal biosensor patches for people with diabetes to continuously monitor glucose levels and metabolic health biomarkers.

Prolynx

The company develops long-acting medicines for obesity and metabolic conditions using proprietary drug delivery technology for patients requiring less frequent dosing.

NanoPass Technologies

This company develops microneedle-based intradermal delivery devices for healthcare providers and pharmaceutical companies to administer vaccines, drugs and aesthetic treatments.